C18 C64
Conditions
Interventions
Group 1: Patients undergo standard of care treatment and will not be treated or diagnosed differently due to the trial. The only intervention patients undergo is the ex vivo processing of removed tiss
Sponsors
Universitätsklinikum Augsburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: previously untreated colon cancer or renal cell cancer with indication for hemicolectomy or nephrectomy, respectively; size of the tumor to be resected = 2 cm; ability to understand the protocol and give informed consent
Exclusion criteria
Exclusion criteria: medical or psychological impairments or legal restrictions resulting in reduced capability to give informed consent; lack of any of the listed inclusion criteria; if histopathological workup after the library perfusion will unexpectedly yield a diagnosis other than the expected colon or renal cell cancer, respectively, the patient will be excluded from the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility of the procedure to identify specific vector capsid-displayed peptides targeting human tumors ex vivo | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification of vector-displayed peptides targeting human tumors ex vivo | — |
Countries
Germany
Contacts
Public ContactMartin Trepel
Universitätsklinikum Augsburg
Outcome results
None listed